HYDRODIURIL Drug Patent Profile
✉ Email this page to a colleague
When do Hydrodiuril patents expire, and what generic alternatives are available?
Hydrodiuril is a drug marketed by Merck and is included in one NDA.
The generic ingredient in HYDRODIURIL is hydrochlorothiazide. There are thirty-two drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Hydrodiuril
A generic version of HYDRODIURIL was approved as hydrochlorothiazide by PRINSTON INC on March 29th, 2002.
Summary for HYDRODIURIL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 134 |
Clinical Trials: | 7 |
Patent Applications: | 3,847 |
Formulation / Manufacturing: | see details |
DailyMed Link: | HYDRODIURIL at DailyMed |
Recent Clinical Trials for HYDRODIURIL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
The First Affiliated Hospital of Zhengzhou University | Phase 4 |
Ruijin Hospital | Phase 4 |
Zhongda Hospital | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for HYDRODIURIL
US Patents and Regulatory Information for HYDRODIURIL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Merck | HYDRODIURIL | hydrochlorothiazide | TABLET;ORAL | 011835-003 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Merck | HYDRODIURIL | hydrochlorothiazide | TABLET;ORAL | 011835-006 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Merck | HYDRODIURIL | hydrochlorothiazide | TABLET;ORAL | 011835-007 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |